Normally, PD-L1 is expressed on antigen-presenting cells (APCs) and interacts with PD-1 on T cells to reduce CTL activity in the immune response; that expressed on tumor cells inhibits the interaction between T cells and APCs, resulting in the evasion of CTL attack [199]. This evidence concerns the gene PDCD1 and neoplasm.